We compared the effectiveness between starting with oral versus subcutaneous MTX over the first year. Longitudinal multivariable models, adjusted for potential baseline and time-varying confounders, ...

Hympavzi is the first once-weekly subcutaneous treatment for people living with haemophilia B administered using a pen-injector and the first treatment administered as a flat dose – i.e., not ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version ... in the US for TAR-200 as a treatment for non-muscle-invasive ...

In the EU, rozanolixizumab is indicated as an add-on to standard therapy for the treatment of generalized myasthenia gravis (gMG ... leading to patients feeling vulnerable and lacking control.

When both options provide excellent outcomes, it becomes essential to listen to the patient to determine their preferences. For example, would subcutaneous treatment be more appealing than ...

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

Totality of data observed with subcutaneous lonigutamab in Thyroid Eye Disease (TED) patients demonstrate potential for efficacy in line with standard of care and a more favorable safety profile ...